
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
Sarah Crafton, MD, details how sentinel lymph node mapping can help identify the stage of uterine cancers and lead to better patient care.
Sarah Crafton, MD, gynecologic oncologist at Allegheny Health Network in Pittsburgh, Pennsylvania, details how sentinel lymph node mapping can help identify the stage of uterine cancers and lead to better patient care.